Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes

Modern Rheumatology

Volumn 19, Issue 6, 2009, Pages 590-599

  Wiik, Allan ^a,b  

^a STATENS SERUM INSTITUT   (Denmark)

^b NONE   (Denmark)

Author keywords

ANCA; Diagnosis; Pathophysiology; Vasculitis

Indexed keywords

ELASTASE; EPITOPE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANCA ASSOCIATED VASCULITIS; ANTIBODY BLOOD LEVEL; ANTIGEN PURIFICATION; CELL MEMBRANE PERMEABILITY; CHURG STRAUSS SYNDROME; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; MICROSCOPIC POLYANGIITIS; NEUTROPHIL; PATHOPHYSIOLOGY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; SENSITIVITY AND SPECIFICITY; STAINING; WEGENER GRANULOMATOSIS;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CYTOPLASM; HUMANS; MYELOBLASTIN; NEUTROPHILS; PANCREATIC ELASTASE; PEROXIDASE;

EID: 73349128410     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0219-4     Document Type: Review

References (80)

1. P Calabresi EA Edwards RF Schilling 1959 Fluorescent anti-globulin studies in leukopenic and related disorders J Clin Invest 38 2091 2100 10.1172/JCI103987 1:STN:280:DyaF3c7islalsw%3D%3D 13806846
2. Wiik A. Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy. 1980;35:263-89.
3. Davies D, Moran ME, Niall JF, Ryan GB. Segmental glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology. Br J Med. 1982;285:606.
4. FJ van der Woude N Rasmussen S Lobatto A Wiik H Permin LA van Es M van der Giessen GK van der Hem TH The 1985 Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis Lancet 1 425 429 2857806
5. A Wiik FJ van der Woude 1990 The new ACPA/ANCA nomenclature Netherland J Med 36 107 109 1:STN:280:DyaK3c3oslejsA%3D%3D
6. A Wiik 1989 Delineation of a standard procedure for indirect immunofluorescence detection of ANCA Acta Pathol Microbiol Scand 97 Suppl 6 12 13
7. J Lüdemann B Utecht WL Gross 1988 Detection and quantitation of anti-neutrophil cytoplasmic antibodies in Wegener's granulomatosis by ELISA using affinity-purified antigen J Immunol Methods 114 167 174 10.1016/0022-1759(88)90169-X 3053908 (Pubitemid 18260023)
8. J Wieslander N Rasmussen P Bygren 1989 An ELISA for ANCA and preliminary studies of the antigens involved Acta Pathol Microbiol Immunol Scand 97 6 42
9. JL Niles RT McCluskey ME Ahmad MA Arnout 1989 Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase Blood 74 1888 1893 1:CAS:528:DyaK3cXhvFOqsw%3D%3D 2679910
10. Goldschmeding R, van der Schoot CE, Ten Bokkel Huinink D, Hack CE, van den Ende ME, Kallenberg CG, von dem Borne AE. Wegener's granulomatosis autoantibodies idenfy a novel diiso-fluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest. 1989;84:1577-87.
11. DE Jenne 1994 Structure of azurocidin, proteinase 3, and neutrophil elastase genes. Implications for inflammation and vasculitis Am J Resp Crit Care Med 150 S147 S154 1:STN:280:DyaK2M%2FktVeqsA%3D%3D 7952651
12. P Bini JE Gabay A Teitel M Melchior JL Zhou KB Elkon 1992 Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3 J Immunol 149 1409 1415 1:CAS:528:DyaK38XmtlWqsbY%3D 1380042
13. M Fujinaga M Chernaia R Halenbeck K Koth MN James 1996 The crystal structure of PR 3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies J Mol Biol 261 267 278 10.1006/jmbi.1996.0458 1:CAS:528:DyaK28XltFKrt74%3D 8757293 (Pubitemid 26275808)
14. N Müller-Bérat J Minowada K Tsuji-Takayama H Drexler M Lanotte J Wieslander A Wiik 1994 The phylogeny of proteinase 3/myeloblastin, the autoantigen in Wegeren's granulomatosis, and myeloperoxidase as shown by immunohistochemical studies on human leukemic cell lines Clin Immunol Immunopathol 70 51 59 10.1006/clin.1994.1010 8261669 (Pubitemid 24034689)
15. ME Griffith S Coulthart A Pemberton AJ George CD Pusey 2001 Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site Clin Exp Immunol 123 170 177 10.1046/j.1365-2249.2001.01420.x 1:CAS:528:DC%2BD3MXhtF2mt7c%3D 11168015 (Pubitemid 32118854)
16. YM van der Geld PC Limburg CGM Kallenberg 1999 Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies Clin Exp Immunol 118 487 496 10.1046/j.1365-2249.1999.01079.x
17. YM van der Geld AT Tool J Videler M de Haas JM Tervaert CM Stegeman, et al. 2002 Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active or remission in Wegener's granulomatosis Clin Exp Immunol 129 562 570 10.1046/j.1365-2249.2002.01926.x 12197900 (Pubitemid 35024928)
18. RJ Falk JC Jennette 1988 Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis New Engl J Med 318 1651 1657 1:STN:280:DyaL1c3jt1yhuw%3D%3D 2453802
19. Jennette JC, Falk RN. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis. 1990;15:517-29.
20. Franssen C, Gans R, Kallenberg CGM, Hageluken C, Hoorntje S. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med. 1998;244:209-16.
21. RJ Falk R Becker R Terrell CJ Jennette 1992 Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase Clin Exp Immunol 89 274 278 1:CAS:528:DyaK38XmsV2rsrY%3D 1379133
22. KS Chang W Schroeder MJ Siciliano LH Thompson K McCredie M Beran, et al. 1987 The localization of the human myeloperoxidase gene is in close proximity to the translocation breakpoint in acute promyelocytic leukaemia Leukemia 1 458 462 1:CAS:528:DyaL2sXkvFWis7o%3D 2823022
23. K Taylor J Pohl JM Kinkade 1992 Unique autolytic cleavage of human myeloperoxidase J Biol Chem 267 25282 25288 1:CAS:528:DyaK3sXkvV2rtLg%3D 1334087
24. EC Hagen M Daha J Hermans K Andrassy E Csernok G Gaskin 1998 The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis Kidney Int 53 743 753 10.1046/j.1523-1755.1998.00807.x 1:STN:280:DyaK1c7mvVSlsQ%3D%3D 9507222 (Pubitemid 28124291)
25. M Segelmark B Baslund J Wieslander 1994 Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern Clin Exp Immunol 96 458 465 1:CAS:528:DyaK2cXltVKgu78%3D 7516271
26. HK Choi PA Merkel AM Walker JL Niles 2000 Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies Arthritis Rheum 43 405 413 10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5 1:CAS:528:DC%2BD3cXhs1aqtbs%3D 10693882 (Pubitemid 30395751)
27. A Wiik 2008 Drug-induced vasculitis Curr Opin Rheumatol 20 35 39 10.1097/BOR.0b013e3282f1331f 18281855 (Pubitemid 351339430)
28. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Scand. 1989;97:12-3.
29. Wiik AS. Clinical use of serological tests for antineutrophil cytoplasmic antibodies. What do the studies say? Rheum Dis Clin North Am. 2001;27:799-813.
30. Wiik A. Antineutrophil cytoplasm antibodies (ANCAs) and strategy for diagnosing ANCA-associated vasculitides. In: Detrick B, Hamilton RG, Folds JD, editors. Manual of molecular and clinical laboratory immunology. Washington DC: ASM Press; 2006. p. 1053-8.
31. J Savige D Gillis E Benson D Davies V Esnault RJ Falk, et al. 1999 International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA) Am J Clin Pathol 111 507 513 1:STN:280: DyaK1M3gslCqtw%3D%3D 10191771
32. J Savige W Dimech M Fritzler J Goeken EC Hagen JC Jennette, et al. 2003 Addendum to the international consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases Am J Clin Pathol 120 312 318 10.1309/WAEPADW0K4LPUHFN 1:CAS:528:DC%2BD3sXnvVWis70%3D 14502794
33. A Wiik 2002 Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases Autoimmun Rev 1 67 72 10.1016/S1568-9972(01)00007-6 1:CAS:528:DC%2BD38Xlt1Clsb4%3D 12849061 (Pubitemid 38367428)
34. EC Hagen K Andrassy E Csernok MR Daha G Gaskin W Gross 1993 The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays J Immunol Methods 159 1 16 10.1016/0022-1759(93) 90136-U 1:CAS:528:DyaK3sXksVOjsr0%3D 8445241 (Pubitemid 223036050)
35. MJ Fritzler A Wiik ML Fritzler SG Barr 2003 The use and abuse of commercial kits used to detect autoantibodies Arthritis Res Ther 5 192 201 10.1186/ar782 1:CAS:528:DC%2BD3sXlvVShtr8%3D 12823850
36. Wiik AS, Gordon TP, Kavanaugh AF, Lahita RG; Reeves W, van Venrooij WJ, et al. Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum (Arthritis Care Res). 2004; 51:291-8.
37. Goldschmeding R, van der Schoot CE, van der Snoek MA, von dem Borne AEG. A monoclonal antibody against the 29 kD ANCA antigen: application as catching antibody in a sandwich ELISA for ANCA detection. Acta Pathol Microbiol Immunol Scand. 1988;97:47.
38. M Segelmark BD Phillips SL Hogan RJ Falk JC Jennette 2003 Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis Clin Diagn Lab Immunol 10 769 774 1:CAS:528: DC%2BD3sXotVehs7k%3D 12965902
39. J Damoiseaux C Dähnrich A Rosemann C Probst L Komorowski CA Stegeman, et al. 2009 A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase 3 significantly improves the diagnostic potential for anti-neutrophil cytoplasmic antibody-associated vasculitis Ann Rheum Dis 68 228 233 10.1136/ard.2007.086579 1:CAS:528: DC%2BD1MXisVSjs7s%3D 18375539
40. D Villalta E Tonutti M Tampoia N Bizzaro W Papisch L Tozolli, et al. 2004 Analytical and diagnostic accuracy of the ELiA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection Clin Chem Lab Med 42 1161 1167 10.1515/CCLM.2004.236 1:CAS:528:DC%2BD2cXpslOhurw%3D 15552276 (Pubitemid 39481158)
41. The international serum standard of anti-neutrophil cytoplasm antibodies (ANCA) according to the 1st International Workshop on ANCA, 1988. Acta Pathol Microbiol Immunol Scand. 1988;97:30.
42. Wieslander J, Witt L, Wiik A. The development of an international reference preparation for ANCA (abstract). APMIS 2009;117:180.
43. JC Jennette RJ Falk K Andrassy PA Bacon J Churg WL Gross, et al. 1994 Nomenclature of systemic vasculitides: proposal of an international consensus conference Arthritis Rheum 37 187 192 10.1002/art.1780370206 1:STN:280:DyaK2c7nsF2mug%3D%3D 8129773
44. L Guillevin B Durand-Gasselin R Cevallos M Gayraud F Lhote P Callard, et al. 1999 Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients Arthritis Rheum 42 421 430 10.1002/1529-0131(199904)42: 3<421::AID-ANR5>3.0.CO;2-6 1:STN:280:DyaK1M7os1Khtg%3D%3D 10088763 (Pubitemid 29136088)
45. JW Cohen Tervaert FJ van der Woude AS Fauci JL Ambrus J Velosa J Keane, et al. 1989 Association between active Wegener's granulomatosis and anticytoplasmic antibodies Arch Int Med 149 2461 2465 10.1001/archinte.149.11. 2461 (Pubitemid 19283202)
46. MM Chen Y Feng Y Zhang W-Z Zou M-H Zhao H-Y Wang 2005 Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies Kidney Int 68 2225 2229 10.1111/j.1523-1755.2005.00679.x 1:CAS:528:DC%2BD2MXht1SgtbfN 16221222 (Pubitemid 43117797)
47. Sable-Fortassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med. 2005;143:632-8.
48. A Wiik 1993 Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis Clin Exp Rheumatol 11 191 201 1:STN:280:DyaK3s3osVOlug%3D%3D 8508563
49. Bang la Cour B, Wiik A, Høier-Madsen M, Baslund B. Clinical correlates and substrate specificities of antibodies exhibiting neutrophil nuclear reactivity-a methodological study. J Immunol Methods. 1995;187:287-95.
50. MM Boomsma CA Stegeman MJ van der Leij W Ooost J Hermans CGM Kallenberg, et al. 2000 Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study Arthritis Rheum 43 2025 2033 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O 1:STN:280:DC%2BD3cvmt1ejsw%3D%3D 11014352 (Pubitemid 30953265)
51. DR Jayne G Gaskin CD Pusey CM Lockwood 1995 ANCA and predicting relapse QJM 88 127 133 1:STN:280:DyaK2M3hvFChug%3D%3D 7704563
52. J De'Oliviera G Gaskin A Dash AJ Rees CD Pusey 1995 Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis Am J Kidney Dis 25 380 389 10.1016/0272-6386(95)90098-5 7872315
53. RA Sinico A Radice C Corace L DiToma E Sabadini 2005 Value of new automated fluorescence immunoassay (ELiA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis Ann NY Acad Sci 1050 185 192 10.1196/annals.1313.019 1:CAS:528:DC%2BD2MXhtVWgtrrE 16014533 (Pubitemid 41129435)
54. JW Cohen Tervaert R Goldschmeding JD Elema PC Limburg M van der Giessen MG Huitema, et al. 1990 Association of autoantibodies to myeloperoxidase with different forms of vasculitis Arthritis Rheum 33 1264 1272
55. R Birck WH Schmidt IA Kaelsch FJ van der Woude 2006 Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review Am J Kidney Dis 47 15 23 10.1053/j.ajkd.2005.09. 022 16377381 (Pubitemid 41828262)
56. C Franssen R Gans C Kallenberg C Hageluken S Hoorntje 1998 Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies J Intern Med 244 209 216 10.1046/j.1365-2796.1998.00357.x 1:STN:280:DyaK1cvhvVGitw%3D%3D 9747743 (Pubitemid 28389657)
57. Wiik A. Autoantibodies in vasculitis. In: Hall G, Bridges L, editors. Vasculitis. 2nd ed. Oxford: Oxford University Press; 2008. p. 53-65.
58. B Bonaci-Nikolic MM Nikolic S Andrejevic S Zoric M Bukilica 2005 Antineutrophil cytoplasmic antibody (ANCA) Associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitis Arthr Res Ther 7 R1072 R1081 10.1186/ar1789 1:CAS:528:DC%2BD2MXpvFOgurc%3D
59. RL Rubin 2005 Drug-induced lupus Toxicology 15 135 147 10.1016/j.tox.2004.12.025 (Pubitemid 40568641)
60. Meroni PL, Del Papa N, Raschi E, Tincani A, Balestrieri G, Youinou P. Antiendothelial cell antibodies (AECA): from laboratory curiosity to another useful autoantibody. In: Shoenfeld Y, editor. The decade of autoimmunity. Amsterdam: Elsevier Science; 1999. p. 285-94.
61. C Holmen M Christensson E Pettersson J Bratt P Stjärne A Karrar, et al. 2004 Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies Kidney Int 66 1049 1060 10.1111/j.1523-1755. 2004.00853.x 15327398 (Pubitemid 39121009)
62. C Holmen E Elsheik M Christensson J Liu AS Johannsson AR Qureshi, et al. 2007 Anti-endothelial antibodies selective activate SAPK/JNK signalling in Wegener's granulomatosis J Am Soc Nephrol 18 2497 2502 10.1681/ASN.2006111286 1:CAS:528:DC%2BD2sXhtV2murrN 17699811 (Pubitemid 47378866)
63. Rutgers A, Heeringa P, Damoiseaux JG, Cohen Tervaert JW. ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur J Intern Med. 2003;14:287-95.
64. JB Levy T Hammad A Coulthart T Dougan CD Pusey 2004 Clinical features and outcome of patients with both ANCA and anti-GBM antibodies Kidney Int 66 1535 1540 10.1111/j.1523-1755.2004.00917.x 1:CAS:528:DC%2BD2cXpsVShu7c%3D 15458448 (Pubitemid 39298387)
65. ML Vecchi A Radice F Renda G Mule RA Sinico 2000 Anti-laminin autoantibodies in ANCA-associated vasculitis Nephrol Dial Transpl 15 1600 1603 10.1093/ndt/15.10.1600 1:STN:280:DC%2BD3M%2FktVWrtA%3D%3D
66. FD Moodie B Leaker G Cambridge NF Totty AW Sega 1993 Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis Kidney Int 43 675 681 10.1038/ki.1993.97 1:CAS:528:DyaK3sXitlaju7o%3D 8455367
67. N Del Papa L Guidali A Sala C Buccelati M Khamashta K Ichikawa, et al. 1996 Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion Arthritis Rheum 39 758 766 10.1002/art.1780390507 1:STN:280:DyaK283ht1CgtA%3D%3D 8639172 (Pubitemid 26140420)
68. Del Papa N, Guidali N, Tincani A, Balestrieri G, Ishikawa I, Koike T. Endothelial cells as targets for antiphospholipid antibodies: human polyclonal and monoclonal anti-β2 glycoprotein I react in vitro with endothelial cells through adherent β2 glycoprotein I and induce endothelial cell activation. Arthritis Rheum. 1997;40:551-61.
69. JD Rees S Lanca PV Marques JA Gómes-Puerta R Moco C Olivieri, et al. 2006 Prevalence of the antiphospholipid syndrome in primary systemic vasculitis Ann Rheum Dis 65 109 111 10.1136/ard.2004.034231 1:STN:280: DC%2BD28%2FgtlOitA%3D%3D 16344494 (Pubitemid 41815649)
70. CG Kallenberg 2008 Pathogenesis of PR3-ANCA associated vasculitis J Autoimmun 30 29 36 10.1016/j.jaut.2007.11.005 1:CAS:528:DC%2BD1cXlvFSjsQ%3D%3D 18162369
71. JC Jennette RJ Falk 2008 New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies Curr Opin Rheumatol 20 55 60 10.1097/BOR.0b013e3282f16c0a 1:CAS:528:DC%2BD1cXhtlSis7c%3D 18281858 (Pubitemid 351339432)
72. Pankhurst T, Nash G, Williams J, Coleman R, Hussain A, Savage C. Influence of IgG subclass on neutrophil adhesive behaviour and relevance to anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (abstract). APMIS 2009;117:132.
73. van Timmeren MM, Chen M, Heeringa P. Pathogenic role of complement activation in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Nephrology (Carlton). 2009;14:16-25.
74. A Schreiber H Xiao JC Jennette W Schneider FC Luft R Kettriz 2009 C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis J Am Soc Nephrol 20 289 298 10.1681/ASN.2008050497 1:CAS:528:DC%2BD1MXjtFCrt7Y%3D 19073822
75. Rothermel AL, Wang Y, Schechner J, Mook-Kanamori B, Aird WC, Pober JS, et al. Endothelial cells present antigens in vivo. BMC Immunol. 2004;5:5.
76. L Harper JM Williams CO Savage 2004 The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis Biochem Soc Trans 32 502 506 10.1042/BST0320502 1:CAS:528:DC%2BD2cXksFyhtrw%3D 15157172 (Pubitemid 38813549)
77. GA Preston CS Zarella WF Pendergraft EH Rudolf JJ Yang SB Sekura 2002 Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappa B and proapoptotic changes in JNK ERK, and MAPK signalling pathways J Am Soc Nephrol 13 2840 2849 10.1097/01.ASN.0000034911.03334.C3 1:CAS:528:DC%2BD38XoslSntrY%3D 12444202 (Pubitemid 35386903)
78. WF Pendergraft EH Rudolf RJ Falk JE Jahn M Grimmler L Hengst, et al. 2004 Proteinase 3 sidesteps caspases and cleaves p21 (Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis Kidney Int 65 75 84 10.1111/j.1523-1755.2004.00364.x 1:CAS:528:DC%2BD2cXmt1Wjsg%3D%3D 14675038 (Pubitemid 38040086)
79. JJ Yang GA Preston WF Pendergraft M Segelmark P Heeringa SL Hogan, et al. 2001 Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants Am J Pathol 158 581 592 1:CAS:528:DC%2BD3MXhsFWmt7c%3D 11159195
80. Astern JM, Pendergraft WF, Falk RJ, Jennette JC, Schmaier AH, Mahdi F, et al. Myeloperoxidase interacts with endothelial cell surface cytokeratin 1 and modulates bradykinin production by the plasma kallikrein-kinin system. Am J Pathol. 2007;171:349-60.